Enovix Corp shares traded higher on Wednesday after the company announced a purchase order for 100,000 battery units from a multinational provider of dual-use drone systems. The stock rose 5.58% to $2.64 during regular trading hours, following an 11.55% jump in previous after-hours sessions.

Order details and pipeline conversion

The initial order is for 100,000 battery units, with deliveries scheduled for the first half of 2027. The cells will be manufactured at Enovix’s TAA-compliant, military-qualified facility in South Korea. Steve Bakos, chief revenue officer and general manager, stated that the order demonstrates Enovix’s ability to deliver high-performance batteries from a qualified, non-Chinese source. The company did not disclose the order’s dollar value or the customer’s name.

This transaction moves one opportunity from Enovix’s roughly $216 million drone, defense, and industrial pipeline into backlog. The company noted that this order is among the fourth-quarter 2026 purchase orders. Following successful initial deployment, the customer is expected to place follow-on orders for the program in the second half of 2027 and beyond.

Q3FY26 financial performance

Earlier, Enovix reported preliminary third-quarter fiscal year 2026 revenue of $11 million, marking a 38% increase year-over-year and exceeding its guidance range of $9 million to $10 million. This marks the sixth consecutive quarter of year-over-year revenue growth. Drone and defense customers accounted for nearly 70% of quarterly revenue, highlighting the company's strategic pivot toward high-margin industrial applications.

The combined pipeline for drone, defense, and industrial sectors increased 18% to $216 million. Notably, the drone-specific pipeline surged 48% to nearly $150 million, reflecting accelerating adoption in aerial, subsea, and maritime programs. Enovix clarified that the pipeline represents its estimate of the peak annual production value of identified design opportunities and does not represent contracted or committed revenue.

To capitalize on the demand for non-Chinese batteries among US and allied defense programs, Enovix is investing $19 million to double production capacity at its South Korean manufacturing facility. Interim CEO Ryan Benton noted that purchase orders received early in the fourth quarter already surpassed total third-quarter revenue.

Financial metrics and balance sheet

The company reported a non-GAAP operating loss of $29.2 million, compared to guidance of $29 million to $32 million. Non-GAAP loss per share stood at 14 cents, within the guided range of 13 cents to 17 cents. As of October 4, Enovix held $512 million in cash and cash equivalents.

What the numbers show

A divergence exists between top-line acceleration and bottom-line stability. While revenue grew 38% YoY, the operating loss remained substantial at $29.2 million, indicating that scale has not yet translated into profitability. However, the concentration of 70% of revenue from drone and defense segments suggests a high dependency on this specific vertical for near-term growth, mitigating risk from broader consumer electronics volatility. The new order confirms the pipeline-to-backlog conversion rate, validating the demand signal seen in the Q3 results.

Leadership realignment

Enovix realigned its leadership team to support rising order mandates across multiple sub-markets. The company promoted Steve Bakos to chief revenue officer and general manager, while James Wilcox was named vice president of Corporate Strategy. Additionally, Dan Wark was hired to lead the new global supply chain organization, focusing on consolidating production planning, procurement, and sourcing.

Market performance and analyst outlook

The stock carries a Buy rating with an average price forecast of $12.94 across 11 analysts. Recent analyst moves include:

• StoneX: Buy (target lowered to $10)
• William Blair: Downgraded to Market Perform
• Canaccord Genuity: Buy (target lowered to $10)

Enovix has a market capitalization of about $550.82 million. The stock has declined 80.72% over the past 12 months, trading near its 52-week low of $2.40.

Enovix Corporation (NASDAQ: ENVX) reported second-quarter FY26 revenue of $9 million, a 21% increase year over year. The battery technology firm ended the quarter with $552.1 million in cash, supporting its expansion across smartphones, smart eyewear, and defense markets.

The results marked the fifth consecutive quarter of year-over-year revenue growth. Management highlighted progress in qualifying silicon anode cells for smartphones and ramping production for smart eyewear customers.

Financial Performance

Enovix delivered positive gross profit for the seventh consecutive quarter on both GAAP and non-GAAP bases. The financial highlights include:

*Derived from stated 21% growth.

Non-GAAP operating expenses rose to $30.6 million from $28.8 million a year ago, reflecting continued investment in smartphone qualification and manufacturing readiness. Adjusted EBITDA improved to negative $18.9 million from negative $20.1 million in the prior year period.

What the Numbers Show

While revenue grew 21%, the non-GAAP gross margin contracted to 19.9% from the prior year period. Management attributed this decline primarily to product mix shifts within the South Korea operations rather than execution issues. This divergence suggests that current volume growth is driven by lower-margin SKUs or early-stage commercial ramps that have not yet achieved scale efficiencies.

Operational Milestones

Smartphone Qualification

The lead customer confirmed Enovix cells passed more than 1,000 cycles in the 0.2 C discharge test. A final accelerated cycle life test is underway, with completion expected by the end of 2026. Sample deliveries to a second smartphone OEM are planned for the fourth quarter.

Smart Eyewear Ramp

Enovix shipped approximately 2,100 batteries to a Tier 1 customer in Q2, recording its first product revenue in this segment. The company has orders for roughly 19,000 packs for the third quarter, representing a nine-fold increase from Q2 volumes.

Defense and Drones

The pipeline for products manufactured in South Korea grew 45% to $183 million, up from $130 million at the end of Q1. Drone opportunities alone now exceed $100 million. More than $40 million of this pipeline is in active testing or design-in stages.

Outlook and Guidance

For the third quarter, Enovix expects revenue between $9 million and $10 million, representing 13% to 25% year-over-year growth. The guidance assumes continued defense shipments and increased smart eyewear deliveries.

Management projects a non-GAAP operating loss between $29 million and $32 million. Capital expenditures are expected to range from $8 million to $12 million, primarily funding Fab 2 upgrades and South Korea capacity expansion targeted for mid-2027.